CBX7 reduces the emergence of breast adenocarcinoma by inhibiting the Wnt/β-catenin pathway via upregulation of the Wnt antagonist DKK-1 expression (Kim et al., 2015). This evidence concerns the gene CBX7 and breast adenocarcinoma.